Toggle Main Menu Toggle Search

Open Access padlockePrints

Cognitive decline and quality of life in incident Parkinson’s disease: the role of attention

Lookup NU author(s): Dr Rachael LawsonORCiD, Professor Alison Yarnall, Dr Gordon Duncan, Dr Tien Kheng Khoo, Daniel Collerton, Professor John-Paul TaylorORCiD, Professor David BurnORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ

Publication type: Article

Publication status: Published

Journal: Parkinsonism and Related Disorders

Year: 2016

Volume: 27

Pages: 47-53

Print publication date: 01/06/2016

Online publication date: 11/04/2016

Acceptance date: 10/04/2016

Date deposited: 12/04/2016

ISSN (print): 1353-8020

ISSN (electronic): 1873-5126

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.parkreldis.2016.04.009

DOI: 10.1016/j.parkreldis.2016.04.009


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
AbbVie
Academy of Medical Sciences
Acadia Pharmaceuticals
ACT
Britannia Pharmaceuticals Ltd.
Cure Parkinson's Trust
EU
Genus
Lockhart Parkinson's Disease Research Fund
Movement Disorder Society
Rosetrees Trust
Wellcome Trust
Addenbrooke's Charitable Trust
Biomedical Research Unit, Newcastle University
Flynn pharmaceuticals
GE Healthcare
GlaxoSmithKline (GSK)
Michael J. Fox Foundation (MJFF)
MRC
National Institute for Health Research (NIHR) Newcastle Biomedical Research Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University
NIHR
NIHR Biomedical Research Centre
Parkinson's UK
Stevenage Biosciences Catalyst
Teva-Lundbeck
UCB
UCB Pharma
J-0802Parkinson's UK

Share